July 30, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Olympus Medical to Release World's First Auto Flourescent Videoscope
 

Tokyo, Feb 5, 2007 (JCN) - Olympus Medical Systems announced the release of Olympus Gif Type RQ260Z
Evis Lucera - a digestive tract video scope used for observing of blood vessels in mucous membranes under infrared light.

Blood vessels are observed this way to assess how far tumors have invaded and therefore how best to treat a particular patient's stomach cancer. Infiltration of the cancer can be deduced by the proliferation of blood cells in the gastrointestinal mucous membranes.

The Evis Lucera video scope comes with a 90x zoom and a button that allows it to switch from normal to narrow band imaging. This special light setting, caused by irradiation of two hemoglobin-absorbed wavelengths, is used to display capillary blood vessels and mucous membranes patterns.

The Evis Lucera will be available from the beginning of February, 2007.



By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Olympus News  
  Announcement Regarding Establishment of Medical Business Venture Company between Olympus and Sony  (Apr 3, 2013)
  Olympus Establishes India Subsidiary  (Nov 4, 2010)
  Digital Camera Sales up 25% from Year Earlier on Economy Models  (Aug 13, 2010)
  Olympus to Acquire U.S. Pulmonary Device Company Spiration  (June 25, 2010)
  Olympus Launches Nondestructive Testing Instrument  (June 2, 2010)
  Olympus "Joint update service for Four Thirds lenses" launched  (Oct 15, 2008)
  Olympus Imaging and Panasonic Announce New Micro Four Thirds System Standard  (Aug 5, 2008)
  Olympus Imaging: The World's Thinnest and Smallest DSLR  (May 12, 2008)
  Olympus to Bolster Medical Biz thru M&As: President  (Mar 19, 2008)
  Olympus Cuts FY '07 Estimates on Slow Digital Camera Sales  (Feb 5, 2008)



 Recent  Medical News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Medical news...

 Recent  Medical News   
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)
Dainippon Screen Launches High-speed Three-dimensional Cell Culture Scanner (Aug 8, 2013)
Daiichi Sankyo Expands Collaborative Drug Discovery Program to Germany, Switzerland, and Austria (Aug 1, 2013)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)